These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 18534666)

  • 1. Whole blood rotation thrombelastometry in subjects undergoing vitamin K antagonist treatment: hypo- or hypercoagulable profiles?
    Spiezia L; Bertini D; Salmaso L; Simioni P
    Thromb Res; 2008; 122(4):568-9. PubMed ID: 18534666
    [No Abstract]   [Full Text] [Related]  

  • 2. Whole blood coagulation assessment using rotation thrombelastogram thromboelastometry in patients with acute deep vein thrombosis.
    Spiezia L; Marchioro P; Radu C; Rossetto V; Tognin G; Monica C; Salmaso L; Simioni P
    Blood Coagul Fibrinolysis; 2008 Jul; 19(5):355-60. PubMed ID: 18600082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices.
    Ganter MT; Hofer CK
    Anesth Analg; 2008 May; 106(5):1366-75. PubMed ID: 18420846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparinase-modified thrombelastometry: inactivation of heparin in plasma samples.
    Cvirn G; Tafeit E; Hoerl G; Janschitz M; Wagner T; Juergens G; Koestenberger M
    Clin Lab; 2010; 56(11-12):585-9. PubMed ID: 21141445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study.
    Mittermayr M; Velik-Salchner C; Stalzer B; Margreiter J; Klingler A; Streif W; Fries D; Innerhofer P
    Anesth Analg; 2009 Mar; 108(3):743-50. PubMed ID: 19224778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombin generation test in patients under anticoagulant therapy with vitamin K antagonists.
    Brocal I; Marco P; Lucas J; Verdú J; Tarín F
    Thromb Haemost; 2009 Mar; 101(3):594-5. PubMed ID: 19277428
    [No Abstract]   [Full Text] [Related]  

  • 7. [General practitioner's considerations if INR doesn't change].
    Dick A; Spannagl M
    MMW Fortschr Med; 2009 Jun; 151(26-29):32-3. PubMed ID: 19739544
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiphospholipid syndrome patients: the performance of Coagucheck XS in the monitoring of Vitamin K-Antagonists.
    Barcellona D; Fenu L; Vannini ML; Piras M; Marongiu F
    Thromb Res; 2012 Apr; 129(4):e168-70. PubMed ID: 22326057
    [No Abstract]   [Full Text] [Related]  

  • 9. [Functional haemostatic tests are fast and reliable by transfusion demanding bleeding].
    Rafiq S; Steinbrüchel DA; Johansson PI
    Ugeskr Laeger; 2011 May; 173(18):1287-90. PubMed ID: 21535979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Possibilities and limitations of thrombelastometry/-graphy].
    Lang T; von Depka M
    Hamostaseologie; 2006 Aug; 26(3 Suppl 1):S20-9. PubMed ID: 16953288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [An increase in the elasticity of blood plasma fibrin clots in vivo and in vitro under the influence of a water-soluble vitamin K analog (vicasol)].
    Matusia II; Bronshteĭn LM
    Biull Eksp Biol Med; 1967 Feb; 63(2):57-60. PubMed ID: 5623616
    [No Abstract]   [Full Text] [Related]  

  • 12. [Are salicoyl-like analgesics vitamin K antagonists? An interpretation of spontaneous subnormal Quick values].
    Zaugg H
    Schweiz Med Wochenschr; 1978 Aug; 108(33):1277-9. PubMed ID: 675220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cofactor role of vitamin K in blood coagulation processes].
    Khalmuradov AG; Shtutman TsM
    Vopr Pitan; 1980; (3):3-11. PubMed ID: 6996327
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of vitamin K antagonist treatment on activated partial thromboplastin time.
    Mulliez SM; Van den Bogaert J; Devreese KM
    Clin Chem Lab Med; 2015 Feb; 53(2):e47-50. PubMed ID: 25153603
    [No Abstract]   [Full Text] [Related]  

  • 15. [Metabolism of a derivative of 4-hydroxy-coumarin: 3(alfa-acetonyl-p-nitrobenzyl)4-hydroxy-coumarin (Sintrom) in man].
    Blatrix C; Charonnat S; Tillement JP; Israel J; Brevet JP; Debraux J; Merlin M
    Rev Fr Etud Clin Biol; 1968 Dec; 13(10):984-95. PubMed ID: 4185223
    [No Abstract]   [Full Text] [Related]  

  • 16. Rapid evaluation of fibrinogen levels using the CG02N whole blood coagulation analyzer.
    Hayakawa M; Gando S; Ono Y; Mizugaki A; Katabami K; Maekawa K; Miyamoto D; Wada T; Yanagida Y; Sawamura A
    Semin Thromb Hemost; 2015 Apr; 41(3):267-71. PubMed ID: 25839869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on hypercoagulable state. II. The application of 131I-labelled fibrinogen for the estimation of intravascular coagulation in human subjects.
    Izak G; Galewski K; Eyal Z
    Thromb Diath Haemorrh; 1967 Dec; 18(3-4):544-51. PubMed ID: 5590243
    [No Abstract]   [Full Text] [Related]  

  • 18. Noncitrated whole blood is optimal for evaluation of postinjury coagulopathy with point-of-care rapid thrombelastography.
    Kashuk JL; Moore EE; Le T; Lawrence J; Pezold M; Johnson JL; Cothren CC; Biffl WL; Barnett C; Sabel A
    J Surg Res; 2009 Sep; 156(1):133-8. PubMed ID: 19577246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biologic control of long-term anti-coagulating therapy with antivitamins K].
    Samama M; Casubolo L
    Angeiologie; 1967; 19(5):37-43. PubMed ID: 5621971
    [No Abstract]   [Full Text] [Related]  

  • 20. [Physiological and physiopathological bases for a rational anticoagulant therapy].
    Raby C
    J Sci Med Lille; 1968 Nov; 86(11):659-94. PubMed ID: 5701301
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.